Cervical cancer: screening, diagnosis and staging

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer is a significant health burden in developing countries, despite global screening efforts.
• While human papillomavirus (HPV) infection is common, cervical cancer is relatively rare, highlighting the effectiveness of early detection.

Purpose of the Study:

• To emphasize the importance of cervical cancer screening programs in reducing mortality.
• To highlight the role of early detection of pre-cancerous lesions in preventing invasive cervical cancer.

Main Methods:

• Review of cervical screening programs and diagnostic tools like Pap tests and HPV DNA tests.
• Adherence to American Cancer Association guidelines for asymptomatic women and post-treatment follow-up.
• Application of FIGO 2009 staging for cervical cancer treatment.

Main Results:

• Screening programs have decreased cervical cancer incidence and mortality by 50-75% in developed nations over 50 years.
• Pap tests and HPV DNA tests are effective in identifying pre-cancerous lesions and managing asymptomatic women.

Conclusions:

• Widespread cervical screening programs are vital for early detection and treatment of pre-cancerous cervical lesions.
• Continued implementation and improvement of screening methods are essential for reducing cervical cancer burden globally.